MELBOURNE, Australia and SAN FRANCISCO, March 02, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
– Company is advancing ATH434 in late-stage clinical development for Multiple System Atrophy, a rapidly progressive neurodegenerative disease with no approved therapies – MELBOURNE, Australia and SAN ...
– Company is advancing ATH434 in late-stage clinical development for Multiple System Atrophy, a rapidly progressive neurodegenerative disease with no approved therapies – MSA is a progressive ...
An experimental drug that Theravance Biopharma touted as a potential first-in-class medicine for multiple system atrophy has failed a Phase 3 study, triggering a corporate shakeup that ends this ...
It's well known that spaceflight causes muscle atrophy and other biological changes in reduced gravity, and especially in ...
A routine training sortie turned critical when an Airbus A320 experienced an engine fire warning, flap malfunctions, and degraded control responses. This aviation report follows how six pilots ...
Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS).
Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...
Hosted on MSN
What is vaginal atrophy? Women’s doctors explain
This age-related condition affects nearly all women, yet few seek medical help. OBGYNs explain the early signs of vaginal atrophy—and why it’s far more common and underreported than most women realize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results